"RDIF and the Gamaleya Institute are ready to sign an agreement on technological transfer and supply raw materials for vaccine production," RIA Novosti quotes the fund.
They noted that the Kharkov plant "Biolek" has the necessary technological capabilities for the production of vaccines based on the human adenoviral vector.
“At the facilities of the enterprise, the first test bottling was made, technologically identical to the production of the Sputnik V vaccine.
The readiness of the plant to produce the finished form of the vaccine is confirmed by the provided video of the technological process, ”added the RDIF.
Earlier it became known that the RDIF and the center.
Gamaleys are ready to produce Sputnik V vaccine in Ukraine and submit documents for its registration there.
The head of the political council of the Ukrainian party "Opposition Platform - For Life" Viktor Medvedchuk believes that Ukraine has the necessary capacities for the production of a Russian vaccine against coronavirus.